Nexxt Spine reveals early clinical evidence and completes enrolment for Nexxt Matrixx 3D-printed devices

Nexxt Spine has announced the completion of enrolment and six-month clinical data collection comparing the Nexxt Matrixx 3D-printed titanium interbody family to polyetheretherketone (PEEK) devices.

Jim Freid, the company’s director of development and clinical studies, said: “Results from the six-month data that was shared with Nexxt Spine demonstrated a significant increase in the fusion rates for both one- and two-level procedures, as compared to PEEK, (82% versus 25%).

“In addition, the analysis of subsidence of the interbody devices had only 11.8% of levels for the Nexxt Matrixx device showing subsidence greater than 2mm, while the PEEK device exhibited 55% of levels, showing that the Nexxt Matrixx technology has intrinsic benefits to patients and their outcomes.”

Nexxt Spine president, Andy Elsbury, added: “Nexxt Spine is grateful to physician researchers at The Ohio State University Wexner Medical Center for their time and effort in completing the six-month review of the study results, and looks forward to the final one-year data review.

“Here at Nexxt Spine we are committed to bringing exceptionally innovative products to the market. The Nexxt Matrixx proprietary 3D-printed technology continues to demonstrate positive clinical outcomes and positively enhance the lives of more patients.”

The post Nexxt Spine reveals early clinical evidence and completes enrolment for Nexxt Matrixx 3D-printed devices appeared first on Spinal News International.

Original Article: (https://spinalnewsinternational.com/nexxt-spine-reveals-early-clinical-evidence-and-completes-enrolment-for-nexxt-matrixx-3d-printed-devices/)